Prostate Cancer - Results from #23080

The dilemma of localizing disease relapse after radical treatment for prostate cancer: Which is the value of the actual imaging techniques? - Abstract May 30, 2013

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: Long-term outcomes - Abstract May 30, 2013

Multiparametric magnetic resonance imaging of prostate cancer - Abstract May 30, 2013

The diagnostic value of conventional MRI in the differentiation of malignant tumor from benign lesion in prostatic peripheral zone - Abstract May 30, 2013

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment - Abstract May 30, 2013

Focal brachytherapy for selected low-risk prostate cancers: A pilot study - Abstract May 30, 2013

Podcast: Castration-resistant prostate cancer: AUA Guideline 2013 commentary, by E. David Crawford, MD May 30, 2013

Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States - Abstract May 30, 2013

Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies - Abstract May 30, 2013

Interstitial hyperthermia of the prostate in combination with brachytherapy: An evaluation of feasibility and early tolerance - Abstract May 30, 2013

Enzalutamide: An evidence-based review of its use in the treatment of prostate cancer - Abstract May 30, 2013

AUA 2013 - Slide Lecture: Introducing a new option before chemotherapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC) May 30, 2013

Minireview: Androgen metabolism in castration-resistant prostate cancer - Abstract May 29, 2013

Magnetic resonance imaging for prostate cancer clinical application - Abstract May 29, 2013

Prostate HistoScanning: A screening tool for prostate cancer? - Abstract May 29, 2013

Assessment of screenees' knowledge on prostate cancer: Results of a questionnaire using the Fact Sheet - Abstract May 29, 2013

Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer - Abstract May 29, 2013

Oncological outcome after primary prostate cryoablation compared with radical prostatectomy: A single-centre experience - Abstract May 29, 2013

Systemic therapy in men with metastatic castration-resistant prostate cancer: A systematic review - Abstract May 29, 2013

Perineural invasion and TRUS findings are complementary in predicting prostate cancer biology - Abstract May 29, 2013

Page 1155 of 1436